Patents by Inventor Peter Belshaw
Peter Belshaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8084596Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.Type: GrantFiled: January 7, 2010Date of Patent: December 27, 2011Assignees: The Board of Trustees of the Leland Stanford Junior University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Peter Belshaw, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless
-
Publication number: 20110003385Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands.Type: ApplicationFiled: January 8, 2010Publication date: January 6, 2011Inventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw
-
Publication number: 20100323420Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.Type: ApplicationFiled: January 7, 2010Publication date: December 23, 2010Inventors: Gerald Crabtree, Stuart Schreiber, David Spencer, Thomas Wandless, Peter Belshaw
-
Publication number: 20090060888Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands.Type: ApplicationFiled: January 31, 2007Publication date: March 5, 2009Inventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw
-
Publication number: 20080050833Abstract: Relative quantification of metabolites by Electrospray Ionization Mass Spectrometry (ESI-MS) requiring a mechanism for simultaneous analysis of multiple analytes in two or more samples. Labeling reagents that are reactive to particular compound classes and differ only in their isotopic kit facilitating relative quantification and providing tangible evidence for the existence of specific functional groups. Heavy and light isotopic forms of methylacetimidate were synthesized and used as labeling reagents for quantification of amine-containing molecules, such as biological samples. Heavy and light isotopic forms of formaldehyde and cholamine were also synthesized and used independently as labeling reagents for quantification of amine-containing and carboxylic acid-containing molecules, such as found in biological samples. Advantageously, the labeled end-products are positively charged under normal acidic conditions involving conventional Liquid Chromatography Mass Spectrometry (LC/MS) applications.Type: ApplicationFiled: March 21, 2007Publication date: February 28, 2008Inventors: Lloyd Smith, Michael Shortreed, Brian Frey, Margaret Phillips, Joshua Coon, Shane Lamos, Casey Krusemark, Peter Belshaw, Madhusudan Patel, Neil Kelleher
-
Publication number: 20070196834Abstract: Synthesis of long chain molecules such as DNA is carried out rapidly and efficiently to produce relatively large quantities of the desired product. The synthesis of an entire gene or multiple genes formed of many hundreds or thousands of base pairs can be accomplished rapidly and, if desired, in a fully automated process requiring minimal operator intervention, and in a matter of hours, a day or a few days rather than many days or weeks. Production of a desired gene or set of genes having a specified base pair sequence is initiated by analyzing the specified target sequence and determining an optimal set of subsequences of base pairs that can be assembled to form the desired final target sequence. The set of oligonucleotides are then synthesized utilizing automated oligonucleotide synthesis techniques. The synthesized oligonucleotides are subsequently selectively released from the substrate and used in a sequential assembly process.Type: ApplicationFiled: August 17, 2006Publication date: August 23, 2007Inventors: Francesco Cerrina, James Kaysen, Mo-Huang Li, Larry Chu, Peter Belshaw, Michael Sussman, Kathryn Richmond
-
Publication number: 20070122837Abstract: A method is disclosed for the direct synthesis of double stranded DNA molecules of a variety of sizes and with any desired sequence. The DNA molecule to be synthesis is logically broken up into smaller overlapping DNA segments. A maskless microarray synthesizer is used to make a DNA microarray on a substrate in which each element or feature of the array is populated by DNA of a one of the overlapping DNA segments. The DNA segments are released from the substrate and held under conditions favoring hybridization of DNA, under which conditions the segments will spontaneously hybridize together to form the desired DNA construct. This method makes possible the remote assembly of DNA sequence, through a process analogous to facsimile transmission of documents, since the information on DNA to be made can be transmitted remotely to an instrument which can then synthesize any needed DNA sequence from the information.Type: ApplicationFiled: January 24, 2007Publication date: May 31, 2007Inventors: Peter Belshaw, Michael Sussman, Francesco Cenrrina, Shane Flickinger
-
Publication number: 20060127926Abstract: A method is disclosed for the direct synthesis of double stranded DNA molecules of a variety of sizes and with any desired sequence. The DNA molecule to be synthesis is logically broken up into smaller overlapping DNA segments. A maskless microarray synthesizer is used to make a DNA microarray on a substrate in which each element or feature of the array is populated by DNA of a one of the overlapping DNA segments. The complement of each segment is also made in the microarray. The DNA segments are released from the substrate and held under conditions favoring hybridization of DNA, under which conditions the segments will hybridize to form duplexes. The duplexes are then separated using a DNA binding agent which binds to improperly formed DNA helixes to remove errors from the set of DNA molecules. The segments can then be hybridized to each other to assemble the larger target DNA sequence.Type: ApplicationFiled: August 29, 2005Publication date: June 15, 2006Inventors: Peter Belshaw, Michael Sussman, Franco Cerrina, James Kaysen, Brock Binkowski, Kathryn Richmond
-
Publication number: 20060078969Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands.Type: ApplicationFiled: July 5, 2005Publication date: April 13, 2006Inventors: Gerald Crabtree, Stuart Schreiber, David Spencer, Thomas Wandless, Steffan Ho, Peter Belshaw
-
Publication number: 20060035325Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.Type: ApplicationFiled: January 18, 2005Publication date: February 16, 2006Applicants: The Board of Trustees of the Leland Stanford Junior University, President and Fellows of Harvard CollegeInventors: Gerald Crabtree, Stuart Schreiber, David Spencer, Thomas Wandless, Peter Belshaw
-
Patent number: 6972193Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins.Type: GrantFiled: December 17, 1999Date of Patent: December 6, 2005Assignees: Board of Trustees of Leland Stanford Junior University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw
-
Patent number: 6891021Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cellsType: GrantFiled: November 13, 2001Date of Patent: May 10, 2005Assignees: Board of Trustees of the Leland Stanford Junior University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Peter Belshaw
-
Publication number: 20040024725Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cellsType: ApplicationFiled: November 13, 2001Publication date: February 5, 2004Inventors: Gerald Crabtree, Stuart Schreiber, David Spencer, Thomas Wandless, Peter Belshaw
-
Patent number: 6316418Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.Type: GrantFiled: April 30, 1999Date of Patent: November 13, 2001Assignees: Board of Trustees of Leland Stanford Junior University, President and Fellows of Harvard CollegeInventors: Gerald Crabtree, Stuart Schreiber, David Spencer, Thomas Wandless, Peter Belshaw, Steffan N Ho
-
Patent number: 6165787Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of this invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the .zeta.Type: GrantFiled: May 29, 1998Date of Patent: December 26, 2000Assignees: Board of Trustees of Leland Stanford Jr. University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Peter Belshaw
-
Patent number: 6140120Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of this invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the .xi.Type: GrantFiled: September 16, 1998Date of Patent: October 31, 2000Assignees: Board of Trustees of Leland Stanford Jr. University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw
-
Patent number: 6063625Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of this invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the .zeta.Type: GrantFiled: September 16, 1998Date of Patent: May 16, 2000Assignees: Board of Trustees of Leland S, Stanford, Jr. University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw
-
Patent number: 6054436Abstract: We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.Type: GrantFiled: May 29, 1998Date of Patent: April 25, 2000Assignees: Board of Trustees of Leland S. Stanford Jr. Univ., President & Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Peter Belshaw
-
Patent number: 6046047Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of tis invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the .zeta.Type: GrantFiled: September 16, 1998Date of Patent: April 4, 2000Assignees: Board of Trustees of Leland Stanford Jr. University, President and Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Peter Belshaw, Steffan N. Ho
-
Patent number: 6043082Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of this invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the .zeta.Type: GrantFiled: September 16, 1998Date of Patent: March 28, 2000Assignees: Board of Trustees of Leland Stanford Jr. Univ., President & Fellows of Harvard CollegeInventors: Gerald R. Crabtree, Stuart L. Schreiber, David M. Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw